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Abstract Type 2 diabetes (T2D) in youth is a relatively novel
condition facing paediatric health care providers. Few exper-
imental trials exist to guide clinical management in this pop-
ulation. Supporting and prescribing modifiable lifestyle be-
haviours is cornerstone in the management of T2D in adults.
Clinical trials in obese adolescents suggest that intensive
lifestyle interventions that include both dietary changes and
increased physical activity elicit clinically meaningful reduc-
tions in weight and improve cardiovascular risk profiles.
Observational studies in youth with T2D suggest that better
diet quality and increased physical activity are associated with
better metabolic control; however, the limited experimental
data available does not support these observations. Trials
evaluating lifestyle monotherapy for the treatment of
hyperglycaemia in youth with T2D do not exist, and the only
study evaluating combined lifestyle and pharmacologic ther-
apy did not show additional benefit over pharmacologic treat-
ment with metformin alone. Physiological and psychosocial
differences between youth and adults with T2D likely con-
tribute to the differences in the effectiveness of lifestyle ther-
apy for improving glycaemic control. The current review
describes these topics in detail and provides recommendations
for paediatric health care providers for the promotion of
lifestyle therapy for the management of hyperglycaemia and
cardiovascular risk factors for youth with T2DM.
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Introduction
Type 2 diabetes in children and adolescents is a novel chronic
disease facing health care providers. As prevalence (0.18–1.2/
1000) [1–5] and incidence rates (0.6–39/100,000 person
years) [2–8] remain low, the majority of clinicians have had
little opportunity to generate clinical experience managing
hyperglycaemia and cardiovascular risk factors in youth with
T2D. Similarly, very few therapeutic trials exist to guide
clinical practice [9, 10••, 11]. Therefore, current management
guidelines rely largely on data from adult studies and expert
consensus [12, 13]. The purpose of this review is to summa-
rize the evidence for the use of intensive lifestyle therapy for
the management of youth with type 2 diabetes and provide
recommendations for future research endeavours.
Youth with T2D are generally characterized by
hyperglycaemia [14, 15], obesity [15–17], cardiovascular risk
factor clustering [14, 17–19, 20•, 21] and adverse mental
health outcomes [22–24]. These factors contribute to a rapid
progression of diabetes-related complications [20•, 25], par-
ticularly renal disease [26, 27]. As adiposity is a primary
driver for insulin resistance [28], hyperglycaemia [29] and a
number of the comorbidities associated with type 2 diabetes
(T2D) [30, 31], lifestyle management, defined herein as an
increase in habitual physical activity and a change in dietary
patterns that result in a daily caloric deficit and enhanced
nutrient intake, is considered cornerstone in the management
of T2D in youth [13, 32, 33]. The current review has three
primary objectives related to the use of lifestyle management
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for the treatment of youth with T2D: (1) summarize the
evidence for the efficacy of changes in lifestyle behaviours
for improving body composition and cardiometabolic risk
factors among obese adolescents; (2) discuss the roles of
unique pathophysiology and poor mental health outcomes as
determinants of the perceived failure of lifestyle therapy in
youth with T2D and (3) highlight novel approaches for pro-
moting lifestyle therapy in youth with T2D.
Evidence for Lifestyle Management in Obese Adolescents
Is Lifestyle Management Efficacious for Improving Body
Composition in Obese Youth?
Systematic reviews and meta-analyses of randomized trials
published over the last decade clearly demonstrate that behav-
ioural interventions that target dietary changes and increased
physical activity lead to favourable changes in body compo-
sition in obese youth [34–41]. Intensive dietary interventions
without adjunct exercise therapy elicit a ∼2 % (95 % CI −2.40
to −1.23 %) weight loss defined as weight, BMI, % body fat,
waist circumference or skinfold thickness, relative to controls
receiving standard dietary recommendations. In a recent posi-
tion statement from the Academy of Nutrition and Dietetics
[37], four dietary strategies for eliciting weight loss in over-
weight and obese youth were recommended: (1) modified
traffic light diet [42], (2) low carbohydrate diet [41, 43, 44],
(3) reduced glycaemic load diets [45, 46] and (4) non-diet
approach [47, 48, 49••, 50]. Systematic reviews have deter-
mined that these strategies are effective in improving body
composition in the short term among overweight and obese
youth, particularly young children. As all dietary strategies
appear to yield similar effects on measures of adiposity, all
four options were endorsed.
Fewer studies have examined the effects of exercise alone
in improving body composition in obese youth; however,
smaller effect sizes were noted in systematic reviews of the
available studies [51, 52••, 53]. Exercise trials lasting
>16 weeks led to a modest overall −0.4 % (95 % CI −0.7 to
−0.1, P=0.006) reduction in percent body fat, −0.2 % (95 %
CI: −0.6 to 0.1, P=0.07) reduction in central obesity and a
weight loss of −2.7 kg (95 % CI −6.1 kg to 0.8 kg, P=0.07)
[54] among overweight and obese youth. A recent trial sug-
gests that among younger obese children, however, super-
vised, structured endurance exercise offered 4+ times per
week yields meaningful reductions in several measures of
adiposity, particularly central adiposity, in a dose-response
manner [55]. Interestingly, trials comparing the efficacy of
adding exercise to a dietary restriction intervention suggest it
does not lead to additional weight loss among obese youth
[52••], however may yield greater improvements in cardio-
metabolic health outcomes (reviewed below).
Supervised intensive lifestyle interventions that include
both diet and exercise components tend to yield greater weight
loss compared with standard weight loss recommendations
[53]. Specifically, reductions in BMI (−1.25 kg/m2, 95 % CI
−2.18 to −0.32) and BMI z score (−0.10, 95 % CI −0.18 to
−0.02) are significantly greater when both diet and exercise
behaviours are targeted in an intensive manner, compared to
dietary modification alone. Studies comparing lifestyle inter-
ventions to usual care also resulted in significant immediate
(−1.30 kg/m2, 95 % CI −1.58 to −1.03) and posttreatment
effects (−0.92 kg/m2, 95 % CI −1.31 to −0.54) on BMI up to
12 months from baseline measures. The effects of these inter-
ventions were greater in children (<12 years) than adolescents
(13–19 years). Regardless of age, however, the effects were
quite variable with reductions as high as −4.3 kg/m2 in one
study and no effect in several others [53]. The variation in
effect size may be related to the intensity of interventions as
medium- to high-intensity interventions (>26 h of total con-
tact) yield significantly greater weight loss than low-intensity
(<10 h of total contact) interventions (standard mean differ-
ence=−1.01, 95% CI −1.24 to −0.78 vs −0.39, 95% CI −0.66
to −0.11) [38]. Not all systematic reviews reveal the same
effects, as school-based [56, 57], community-based [58] and
home-based [59] interventions appear to be ineffective at
reducing measures of adiposity in children and adolescents.
Cochrane reviews on the prevention [60] and treatment [35] of
childhood obesity with modifiable lifestyle approaches sug-
gest that the effects of combined dietary modification and
exercise for weight management in obese youth are heteroge-
neous. Interventions that are more intensive, target younger
children (<12 years) and include both exercise and dietary
modification are associated with the greatest reductions in
measures of adiposity [35, 38, 60]. Taken together, results
from these systematic reviews reveal that intensive, structured
lifestyle interventions, particularly those that include both
exercise and dietary modification, yield modest but meaning-
ful improvements in adiposity in obese children and adoles-
cents. These data suggest that similar strategies may also be
beneficial for obese youth living with T2D.
Is Intensive Lifestyle Management Effective
for Cardiometabolic Risk Factor Management?
Among overweight and obese youth, lifestyle interventions
confer favourable effects on serum lipoprotein profiles, fit-
ness, insulin sensitivity and systolic blood pressure [52••,
61–64]. A recent systematic review found that lifestyle inter-
ventions that elicited significant weight loss in obese youth
(see above) yielded small, but significant reductions in low-
density lipoprotein cholesterol (−0.30 mmol/L, 95%CI −0.45
to −0.15), serum triglycerides (−0.15 mmol/L, 95 % CI −0.24
to −0.07), fasting insulin (−55.1 pmol/L, 95 % CI −71.2 to
−39.1) and blood pressure (−3.4 mmHg, 95 % CI −5.19 to
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−1.61) for up to 12 months [53]. Often these improvements
are achieved with minimal change in body weight.
Importantly, the addition of exercise to a standard dietary
restriction approach led to additional reductions in fasting
glucose (−2.16 mg/dL; 95 % CI −3.78 to −0.72 mg/dL) and
insulin (−2.75 μIU/mL, 95 % CI −4.50 to −1.00) and in-
creased HDL (3.86 mg/dL, 95 % CI 2.70 to 4.63) over a 6-
month period [52••]. These effects were observed without any
additional weight loss achieved with the addition of exercise
to the intervention, suggesting exercise-specific effects are
achievable on metabolic health in obese youth.
Interventions aimed at weight loss in obese youth are also
effective in reducing systolic blood pressure in the short term
[61], regardless of the degree of weight loss. A recent meta-
analysis of obesity prevention trials, delivered in large part in
school-based settings, revealed an overall reduction in both
systolic and diastolic blood pressure of −1.5 mmHg (−0.5 to
−2.5 mmHg) [61]. Interventions with the greatest effects on
blood pressurewere thosewith a follow-up period <12months
(−2.9 vs −0.3 mmHg), those that included both physical
activity and dietary restriction/modification (−2.1 vs +
0.11 mmHg vs diet alone) and those delivered in schools
(−2.75 vs −0.92 mmHg vs multiple settings) [61]. The effect
size for these interventions is rather small from a clinical
standpoint; however, these interventions were, for the most
part, delivered to healthy weight youth and their impact may
be greater in obese youth, particularly those with elevated
blood pressure. Similar results have been described in a recent
systematic review of trials of exercise training on measures of
insulin resistance in youth [62]. Specifically, structured exer-
cise training reduces fasting insulin levels (effect size 0.48
(95 % CI 0.22–0.74, z=3.57, P<0.001) and other measures of
insulin resistance (effect size 0.31 (95 % CI 0.06–0.56), z=
2.39, P<0.05). The effect of exercise on measures of insulin
resistance was greater among youth with an elevated BMI;
however, neither the dose, duration nor type of training mod-
ified the effect of exercise on insulin resistance. Collectively,
results from these systematic reviews suggest that
lifestyle-based interventions, particularly those that in-
clude exercise, elicit small but significant improvements in
several cardiometabolic risk factors, particularly among obese
youth.
Arguably, the most successful clinic-based intervention for
the management of obesity and cardiometabolic risk factors
was developed by Mary Savoye at the Yale Obesity Clinic
[48, 49••, 65–67]. Bright Bodies is a 12-month intervention
delivered twice weekly for 6 months and weekly thereafter.
The intervention includes sessions on goal setting, engineer-
ing your environment to make healthier lifestyle choices,
mental health, coping and self-regulation among others [48,
49••, 65]. Techniques taught to youth and family members
include self-awareness, goal setting, stimulus control, coping
skills training (CST), cognitive behaviour strategies and
contingency management. Importantly, parents played a key
role in the intervention and were taught role modelling of
healthy behaviours and coping strategies. The original trial
revealed that the intervention was associated with significant
reductions in BMI (−3.3 kg/m2), body weight (−7.4 kg), body
fat (−9.2 kg) and percent body fat (−6.0 %) after 12 months
[49••]. The improvement in body composition was associated
with significant improvements in total cholesterol (−12.8 mg/
dL, 95 % CI −3.8 to −21.9 mg/dL) and fasting insulin
(−10.6 μU/mL, 95 % CI −5.7 to −12.1 μU/mL) [49••].
These effects also translated into an increased rate of remis-
sion from impaired glucose tolerance in obese youth with
dysglycaemia [66, 67]. The positive effects of the intervention
remained evident up to 4 years after the intervention ended
[48]. The effects of this intensive, clinic-based multidisciplin-
ary model, suggest that under ideal conditions, clinically
relevant weight loss and positive metabolic health outcomes
are achievable and sustainable in obese youth. As we will
discuss below, unfortunately translating these results to youth
with T2D prove to be challenging.
In contrast to the wealth of experimental trials of lifestyle
therapy for biological outcomes, significantly fewer trials
exist examining the effect of lifestyle behaviours on mental
health outcomes in obese youth. The Creating Opportunities
for Personal Empowerment (COPE) intervention provides
promising evidence that the inclusion of educational materials
that promote self-efficacy, problem solving, stress manage-
ment, coping and communication can positively influence
both mental and biological health outcomes in overweight
adolescents [68]. Compared to standard intervention that pro-
moted simple healthy living messages, the COPE-enhanced
programme led to significant short and long-term reductions
in adiposity, improvement in social skills and lower substance
use in overweight adolescents [68]. A recent systematic re-
view revealed that among children and adolescents, the pro-
motion of structured physical activity, particularly within
schools, is an effective approach for reducing systems of
depression [69]. The effects were particularly robust among
adolescents older than 13 years and those that are overweight
or obese. Currently, there is a significant gap in our under-
standing of the efficacy of the inclusion of positive mental
health strategies within healthy living programmes to support
positive mental health among obese adolescents. As poor
mental health, in the form of depression, anxiety and low
quality of life, is a hallmark complication of obese youth,
strategies to enhance mental health should be considered key
features of behaviour modification approaches for promoting
healthy living, particularly among youth with T2D.
Recommendations for Research
With regard to the prevention of T2D in obese youth, (1) there
are no trials of obese youth with impaired glucose tolerance to
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determine the optimal approach to remission or prevention of
incident T2D; (2) there are no trials describing the role of
lifestyle therapy on measures of depression, anxiety and cop-
ing and (3) few trials have assessed the benefit of adding
positive mental health curricula to standard lifestyle interven-
tions on adiposity and metabolic health outcomes.
Lifestyle Management for Youth with T2D
Do Changes in Healthy Living Enhance Outcomes in Youth
with T2D?
The American Academy of Pediatrics recently released a
technical report on the management of T2D in children and
adolescents [13] and a series of clinical practice guidelines
[70•]. Recommendations for youth with type 2 diabetes in-
clude (1) incorporating the Academy of Nutrition and
Dietetics’ Pediatric Weight Management Evidence-based
Nutrition Practice Guidelines and (2) encouraging that chil-
dren engage in moderate to vigorous exercise for at least
60 min daily and (3) limiting nonacademic “screen time” to
less than 2 h daily [13]. Despite these recommendations,
youth with T2D generally achieve significantly less physical
activity [17], are generally more sedentary [71] and display
lower cardiorespiratory fitness [17, 72] relative to peers with-
out diabetes. Furthermore, youth with T2D display lower diet
quality compared to peers with type 1 diabetes [73].
Specifically, they consume twice the amount of sugar-
sweetened beverages as peers with type 1 diabetes, less likely
to meet recommendations of <10 % of their daily intake of
calories from saturated fat, consume fewer micronutrients
and report consuming more than they would like to [73].
In light of these poor lifestyle behaviours, strategies to
promote healthy lifestyle behaviours should be consid-
ered paramount in the treatment of hyperglycaemia and
comorbidities in youth with T2D.
In contrast to the wealth of experimental trials of lifestyle-
based behaviour modification approaches for normoglycaemic
overweight and obese youth, very little experimental evidence
exists for the efficacy of lifestyle changes on cardiometabolic
health outcomes in youth with type 2 diabetes [13, 32].
Unfortunately, the majority of evidence for the role of lifestyle
approaches to clinical management of glycaemia and comor-
bidities in youthwith T2D come from observational studies and
retrospective chart reviews [18, 70•, 74–77]. For example, in an
effort to understand the effectiveness of lifestyle interventions
for glycaemic control in youth with T2D, we performed a
retrospective analyses of 275 youth with T2D treated at our
centre between 1995 and 2010 [15]. Of the 80 youths that
presented with an HbA1c <9.0 % at diagnosis and had a
follow-up measurement of HbA1c at 12 months, only 54 %
(14 % of the total clinical population) were able to achieve
target glycaemic control (HbA1c <7.0 %) and sustain it for
12 months with lifestyle changes alone [15]. A similar chart
review of youth treated for T2D in centres in Germany and
Austria revealed that very few are treated with lifestyle therapy
alone (<20 %) [78] and poor adherence to therapy and with-
drawal from care made it difficult to assess the long-term
effectiveness of lifestyle therapy alone [78]. A similar trend
was observed in youth treated for T2D in the UK, where
lifestyle interventions alone were ineffective for
glycaemic control [6]. In the absence of therapeutic
trials, these clinical observations suggest that intensive life-
style therapy alone is ineffective for the majority of youth with
T2D. This is a theme that is reflected in current clinical
practice guidelines [13].
While chart reviews do not support the effectiveness of
lifestyle therapy for the treatment of T2D in adolescents, a
series of observational studies suggest that various lifestyle
behaviours are associated with enhanced cardiometabolic risk
profiles [71, 77, 79–81]. For example, youth treated with
lifestyle therapy alone tend to display better glycaemic control
than those treated with oral hypoglycaemic agents and insulin;
however, the cross-sectional nature of the study makes it
impossible to know the direction of this association [79]. In
analyses restricted to youth with T2D, better diet quality
(characterized by achieving adherence to the Dietary
Approaches to StopHypertension (DASH) recommendations)
was associated with a better cardiovascular risk profile [80]
and an attenuated rise in systolic blood pressure over 5 years
[82]. Similarly, decreased time spent watching television was
associated with a significantly attenuated 5-year increase in
HbA1c (1.1 vs 2.2 %, P<0.05) and serum lipoprotein levels
among youth with T2D [81]. While physical activity are
generally lower in youth with T2D compared to peers with
type 1 diabetes (4959±3474 vs 7413±3415 steps/day) [83],
higher levels of activity are associated with better glycaemic
control [77] and self-image [83] in youth with T2D, suggest-
ing that increased activity may enhance self-efficacy among
youth with T2D. In summary, (1) a small sample of youth with
T2D are able to achieve and maintain healthy living behav-
iours; (2) the adoption and maintenance of these behaviours
are associated with a better cardiometabolic risk profile and
(3) physical activity, sedentary time and components of the
DASH diet are potential target behaviours for improving
health outcomes in youth with T2D. Unfortunately, the-
se behaviours are difficult to achieve and do not trans-
late into better control or remission to normoglycaemia in
youth with T2D.
Experimental Trials of Healthy Living Behaviours in Youth
with T2D
To the best of our knowledge, only one therapeutic trial [10••]
and one retrospective analysis [84] have examined the
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efficacy of lifestyle therapy for the management of
hyperglycaemia in youth with T2D. The retrospective analysis
examined the resu l t s of 20 consecu t ive newly
diagnosed children with T2D (14.5±0.4 years) admitted to
hospital for treatment with a ketogenic very-low-calorie diet
[84]. Adolescents were poorly controlled (HbA1c=8.8±
0.6 %) and obese (BMI=43.5±1.8 kg/m2) prior to being
admitted to a clinical research centre to undergo a supervised
ketogenic diet. Adolescents were placed a diet of 680–800 cal
daily that was high in protein (1.5 g/kg body mass), low in
carbohydrates (<30 g daily) and supplemented with
micronutrients and vitamins [84]. After 3 days on the very-
low-calorie diet, the average blood glucose fell from 8.9±1.1
to 5.5±0.4 mmol/L and nearly all patients discontinued
hypoglycaemic medications. The diet resulted in a 12 % re-
duction in BMI after 6 months, which was maintained for up
to 24 months following initiation of the diet. At the end of the
diet (average 60 days), HbA1c dropped from 8.8±0.6 % to
7.4±0.6 % and mean arterial pressure fell from 88.6±2.6 to
82.8±1.9 mmHg [84]. The magnitude of change in HbA1c
was significantly associated with the time spent on the diet.
Changes in BMI and HbA1c were significantly greater than
those achieved in a cohort of patients matched for demograph-
ic variables that were not placed on the very-low-calorie diet
[84]. This study demonstrates that if strict adherence to a
hypocaloric diet is maintained, significant improvements in
glycaemic control and blood pressure are achievable with
lifestyle modifications in youth with T2D. Unfortunately, this
approach is not practical in a real-world setting, and these
effects have been difficult to replicate clinically.
The only large-scale therapeutic trial to assess the effec-
tiveness of lifestyle therapy for the treatment of glycaemic
control in youth with T2D was the Treatment Options for
Type 2 Diabetes in Adolescents and Youth (TODAY) trial
[10••]. The elements of the intervention and justification are
publically available [33]. Behavioural targets included (1)
200–300 min of moderate- to vigorous-intensity exercise
weekly, (2) 1200–1500 daily calorie intake and (3) a reduction
in baseline body weight by 7–10 %. The diet modification
followed the traffic light diet; the physical activity modifica-
tion relied on a modified traffic light plan with the use of
pedometers [33]. Parental support was also a key determinant
of the lifestyle intervention that included appropriate praise
and reward systems and role modelling of healthy living
behaviours [33].
The TODAY trial compared the effectiveness of this inten-
sive lifestyle intervention, combined with daily metformin, to
rosiglitazone and metformin and metformin alone on the
maintenance of target glycaemic control in 699 youths with
T2D that achieved target glycaemic control (HbA1c <7.0 %)
prior to randomization [10••]. After 6 months of intensive
lifestyle therapy combined with daily metformin, youth expe-
rienced a significantly greater reduction in BMI (−0.21 vs +
0.35 kg/m2, P=0.021), fat mass (−1.04 vs −0.01 %, P=0.006)
and absolute fat mass (−0.57 vs +0.69 kg, P=0.029) com-
pared to metformin alone [29]. The greater improvements in
body composition were not sustained at the 24 month follow-
up visit [29]. Interestingly, while the change in body compo-
sition was significantly associated with improvements in in-
sulin sensitivity and HbA1c [29], the additional weight loss
associated with intensive lifestyle did not translate into better
maintenance of glycaemic control [10••]. Specifically, rates of
glycaemic failure (46 vs 51 %) and time to failure (11.8 vs
10.3 months) were similar in the intensive lifestyle group
combined with metformin compared to metformin alone
[10••].
Intensive lifestyle therapy also did not lead to significant
improvements in cardiometabolic risk factors, compared to
metformin alone [85]. These data were surprising considering
the results of meta-analyses of lifestyle interventions in obese
youth presented above. In the absence of adequately powered
trials assessing alternate approaches to intensive lifestyle ther-
apy, the results from the TODAY trial suggest that intensive
lifestyle therapy is not an effective approach for the manage-
ment of hyperglycaemia or cardiometabolic risk in youth with
T2D. Several factors may explain this failure and are impor-
tant in the clinical management of youth with T2D.
Recommendations for Research
With regard to lifestyle management for youth with T2D, (1)
there are no therapeutic trials of intensive lifestyle therapy
alone for the management of hyperglycaemia and cardiomet-
abolic risk, (2) there are no trials describing the role of lifestyle
therapy on mental health outcomes nor their association with
clinical outcomes and (3) more in-depth studies of youth that
successfully adopt and maintain healthy living behaviours are
needed to understand predictors of successful adoption of
lifestyle management.
Why Do Not Lifestyle Interventions Work for Youth
with T2D?
Physiological Factors that Limit the Efficacy of Lifestyle
Management in Youth with T2D
There are several key differences between youth and adults
with T2D that may explain the lack of effectiveness of inten-
sive lifestyle therapy for achieving significant and sustained
reductions in glycaemic control in youth with T2D. First, and
most importantly, the pathophysiological and natural history
of the disease appears to be markedly different between ado-
lescents and adults [86].While in adults the onset and progress
of hyperglycaemia take years to develop, they both occur
more rapidly in youth. Data from the TODAY trial revealed
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that glucose-stimulated insulin secretion (i.e. beta cell func-
tion) declined 20–35 % annually, a rate 3–5-fold faster than
reported rates in adults [86, 87]. As glycaemic control is
dependent on a coupling of beta cell function and insulin
sensitivity [88], an intervention designed to maintain or im-
prove glycaemic control would therefore need to enhance
insulin sensitivity at a rate commensurate or greater than the
loss of beta cell function. Systematic reviews of intensive
lifestyle intervention in obese youth without T2D, suggest
that insulin sensitivity may improve ∼20–25 % immediately
following the intervention [62], however these improvements
are rarely sustainable. To date, the only intervention
capable of achieving such a dramatic and sustained improve-
ment in insulin sensitivity is bariatric surgery [89–91], which
in most cases, leads to immediate normalization of
hyperglycaemia [89–91].
Mental Health and Social Considerations for Lifestyle
Therapy in Youth with T2D
While the unique physiological factors affecting youth with
T2D are important in treatment, the psychosocial factors are
arguably the most important barrier to lifestyle modification
for persons with chronic disease [92]. This is particularly
relevant for youth living with chronic diseases, especially if
it is compounded by obesity [93], as there is a significant
mental health burden associated being obese as a child or
adolescent [94]. In a landmark case-control study, obese ado-
lescents reported significantly poorer quality of life and emo-
tional, social and school functioning, compared to healthy
weight children [95••]. In fact, impaired quality of life was
5.5-fold higher (95 % CI 3.4–8.7) compared to healthy weight
children and no different than children living with cancer (OR
1.3; 95 % CI 0.8–2.3). More recent studies reveal that obese
youth, particularly girls, suffer from higher rates of depression
and anxiety, relative to healthy weight peers [93]. Several
comprehensive reviews have been published over the past
10 years summarizing the burden of depression, anxiety and
stress among obese youth [96–98]; however, few studies have
turned their focus to obese youth with type 2 diabetes. This is a
key gap in the literature as the psychological comorbidities
associated with obesity are compounded by the burden of
chronic disease self-management. We argue that the psycho-
logical comorbidites that cluster in youth with type 2 diabetes
are another significant barrier to adopting healthy living
behaviours.
The hypothesis was derived from observations made in the
clinic inWinnipeg, and from preliminary results from a cohort
study of youth with T2D (iCARE) examining the association
between mental health and complications [99], as well as
results from the TODAY study group [18] and a series of
qualitative studies of youth with T2D in our research centre
[100, 101]. For example, in a qualitative study that included
28 repeated in-depth interviews and visual arts sessions with
eight adolescents with T2D [101], children with T2D revealed
two primary themes that guide their self-care behaviours:
excessive responsibility and fear. While youth were often
perceived as irresponsible by providers and care givers, they
reported significant daily responsibilities including caring for
younger siblings and family members, who may also be
suffering from T2D [101]. A second qualitative grounded
theory study of youth, parents and care providers revealed
that lack of peer support, mental health issues and bullying
were primary barriers to adopting healthy living behaviours
[100]. Cultural and socio-ecological differences were also
noted as key barriers to implementing healthy living targets
within families. Collectively, these data suggest that novel
behaviour modification approaches are needed to engage
youths and families in adopting healthy living behaviours to
support self-management of T2D.
Social determinants of health are cornerstone in the adop-
tion of healthy living behaviours in youth with T2D. For
example, youth-onset T2D disproportionately affects youth
of ethnic/minority groups and the socially disadvantaged
[18, 20•, 26, 102]. Within the TODAY (n=699) cohort,
70 % lived in a single-parent household, 42 % lived in house-
holds with an annual income less than $25,000 and 26% had a
parent/guardian with less than a high school education [18,
102]. In our clinic inWinnipeg, 59% of youth treated for T2D
live in a household within the lowest socioeconomic class for
the province [20•, 26]. These high rates of social distress
combined with the lifelong complex medical regimen associ-
ated with T2D may negatively impact the mental health con-
tinuum in youth with T2D and, as mentioned above [101],
overwhelm youth, making personal well-being a lower imme-
diate priority.
Indeed, rates of depression are common among youth with
T2D [24] and threefold higher in youth with type 1 diabetes
compared to the general population [103, 104•]. In a
population-based sample from the USA, 18 % of youth with
T2D had moderate to severe depression, a rate threefold
higher than youth with type 1 diabetes [104•]. While depres-
sion is an important construct, it is also important to have a
better understanding of other key factors involved in mental
health including emotional distress (symptoms of depression
and anxiety), stress and positive psychological factors and
their role in the management of T2D in youth. In fact,
∼20 % of youth with T2D present with a psychiatric disorder
or neurodevelopmental/behavioural problems at diagnosis
[24]. Moreover, youth with T2D report their quality of life is
lower than peers with type 1 diabetes [104•]. The increased
burden of poor mental health and low quality of life may
explain the failure of lifestyle management, noted by many
clinicians and reported in several chart reviews. These find-
ings also reinforce the need for behavioural interventions
targeted at social determinants of health and/or resilience-
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based approaches may be more appropriate for engaging
youth and their families in adopting healthy living behaviours
that support self-management targets.
How Do We Promote Healthy Living in Youth with T2D?
Peer and Social Support
In an effort to overcome limitations of previous interventions,
our group has recently tested the effectiveness of peer-led
approaches to adopting healthy living behaviours in youth at
risk for T2D [105, 106]. Peer-based models for supporting
self-management of chronic diseases in adolescents are not
novel [107, 108]. Two previous obesity prevention trials dem-
onstrated that peer [109] and social support [110] are more
effective that individual weight-loss strategies in youth. As
adolescents with T2D often report feeling isolated from peers,
marginalized and that support for behaviour change is key to
changing lifestyle, we argue that peer-led approaches may be
more appropriate for behaviour change that supports lifestyle
targets in youth with T2D.
In the two trials performed in our centre, we found that
young children receiving curriculum that supported healthy
living behaviours from older peers experienced significantly
greater reductions in measures of adiposity and improvements
in healthy living knowledge [105, 106]. In both trials, peer
mentoring was delivered within the school setting using
established curriculum grounded in validated theoretical frame-
works. In one case, working with youth in a northern isolated
Indigenous community [106], the theoretical framework was
based in a resiliency centred framework [111, 112]. This ap-
proach targets self-efficacy and avoids direct behaviour modi-
fication for lifestyle management. We adopted this model in
response to previous observations that youth living with and at
risk for T2D often require programmes more relevant to their
immediate needs. Future therapeutic trials of lifestyle therapy
for youth with T2D should consider culturally appropriate
approaches that are tailored to the needs to adolescents.
Social Networks and Social Media
Social media is paramount in the lives of adolescents and
significantly influence their behaviour [113, 114]. The
American Heart Association recently released a statement
regarding the efficacy of social networks in the prevention
and management of childhood obesity [115]. There is signif-
icant evidence that behaviours related to weight are associated
with individuals within social networks [116], in some cases
in a dose-response manner [117]. As overweight and obese
youth are more likely to be socially isolated [118], the use of
social media may be an attractive approach to support behav-
iour modification, particularly using a peer-based approach.
Systematic reviews of web-based approaches to be-
haviour modification in youth revealed mixed results
[119]. In most cases, internet-based approaches lead to
changes in lifestyle behaviours and in some cases re-
ductions in adiposity. The effects of the interventions
are often modest; however, these approaches remain in
their infancy. Future studies aimed at behaviour modification
for lifestyle management in youth with T2D may want to
consider these approaches.
Recommendations for Research
In the context of lifestyle therapy for youth with T2D, there is
a dire need for novel approaches to behaviour modification.
We recommend that researchers focus their attention on (1)
piloting novel approaches to engaging adolescents in pro-
gramming that appeals to them; (2) considering the use of
peer-led approaches whereby older peers, ideally of the same
ethnic background, that have successfully adopted lifestyle
behaviour work with adolescents to support behaviour change
and (3) exploring and piloting social networks to determine if
they are an effective tool for engaging youth in behaviour
change.
Conclusions
In conclusion, lifestyle interventions that include exercise and
diet elicit modest but potentially meaningful changes in mea-
sures of adiposity and cardiometabolic risk in obese children
and adolescents. The effectiveness of the intervention is great-
er with more intense interventions and when delivered at a
younger age. While these studies imply that similar effects are
possible for obese youth with type 2 diabetes, there is
little empirical evidence to support the efficacy of life-
style interventions for the treatment of youth with type
2 diabetes. The reasons for this are multifactorial. Youth
with type 2 diabetes experience more significant and
rapid declines in beta cell function and suffer from
disproportionately higher levels of mental problems
and social adversity. Novel interventions are needed to ad-
dress these issues, and a larger focus on the poor mental
health and quality of life among adolescents with type 2
diabetes needs to be addressed clinically and within future
research studies.
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